Skip to main content
. 2016 Apr 26;46(3):335–342. doi: 10.4070/kcj.2016.46.3.335

Fig. 3.

Fig. 3

Serum levels of the biomarkers at 0, 4, and 12 weeks following AF onset in the control group and the candesartan group (A to D). AF: atrial fibrillation, TIMP-1: tissue inhibitor of matrix metalloproteinase-1.